skip to Main Content

Expert Discusses Developments in Pancreatic Cancer Paradigm

Newsfeed image, light gray text on dark gray background
Emerging data are changing the treatment paradigm in pancreatic cancer, offering patients new options and more personalized care, according to Carlos Becerra, MD.

In an interview during the 2018 OncLive® State of the Science Summit™ on Gastrointestinal Malignancies, Becerra, medical oncologist, Texas Oncology, discussed sequencing strategies, immunotherapy, and practice-changing clinical trials in the field of pancreatic cancer. Read more . . . 

Back To Top